INB03

Drug identity checked against registry records

Also recorded as DN-TNF, XPro1595, XENP345, Quellor

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
INB03 for the Treatment of Pulmonary Complications From COVID-19NCT04370236INMBPhase 2, Phase 3Terminated2021-10-13Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.